MPR: Concise prescription and OTC drug information, side effects and interactions for medical professionals

Drug News

Botox approved for upper limb spasticity

March 10, 2010

The FDA has approved Botox (onabotulinumtoxin A, from Allergan) for the treatment of spasticity in the flexor muscles of the elbow, wrist, and fingers in adults.

Pediaderm HC Complete Kit available for atopic dermatitis

March 09, 2010

Arbor Pharmaceuticals announced the launch of Pediaderm HC Complete Kit which contains Pediaderm HC (hydrocortisone lotion 2%) and nonsteroidal Pediaderm Protective Emollient with Triple Synergy Technology.

Generic timolol maleate ophthalmic gel forming solution available

March 09, 2010

Aton Pharma announced the availability of an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).

Xiaflex available for Dupuytren's contracture

March 08, 2010

BioSpecifics Technologies and Auxilium Pharmaceuticals announced the availability of Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord.

Hizentra approved for primary immunodeficiency

March 05, 2010

The FDA has approved CSL Behring's Hizentra (immune globulin [human] 20% liquid for subcutaneous injection) for the once weekly treatment of primary immunodeficiency.

FDA warns of intravascular hemolysis risk with WinRho SDF

March 10, 2010

The FDA, Cangene, and Baxter have notified healthcare professionals that cases of intravascular hemolysis (IVH) and its complications have been reported in patients treated for immune thrombocytopenic purpura (ITP) with WinRho SDF [Rho(D) immune globulin IV (human)].

OneTouch SureStep glucose meter test strips recalled

February 25, 2010

LifeScan has announced it is conducting a voluntary recall of eight lots of OneTouch SureStep glucose meter test strips because they may provide falsely low glucose results when the glucose level is >400mg/dL.

Phase 3 study of Anturol for the treatment of overactive bladder (OAB)

March 02, 2010

Antares Pharma announced that it has completed enrollment in the double-blind portion of their Phase 3 trial of Anturol (transdermal oxybutynin ATD gel) for the treatment of overactive bladder (OAB).

Marketing approval filed with FDA for Ariva-BDL as first modified risk tobacco product

February 22, 2010

Star Scientific announced that it has filed an application with the FDA for approval to market Ariva-BDL as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009.

ISTODAX

ARZERRA

FANAPT

ACTEMRA

VOTRIENT

New Product: SAPHRIS^® (asenapine) Sublingual Tablets

March 09, 2010

CerefolinNAC^® (L-methylfolate [Metafolin], methylcobalamin, N-acetylcysteine) Caplets: A Novel Approach to Early Memory Loss

January 27, 2010

New Product: Zenpep™ (pancrelipase) Delayed-Release Capsules

January 13, 2010

Recommended Adult Immunization Schedule

March 02, 2010

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

Antiemetic Medications

February 05, 2010

A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.

Catch-Up Immunization Schedule for Children

February 02, 2010

A catch-up immunization schedule for children 4 months to 18 years of age. The tables show minimum intervals between doses for children who have delayed immunizations.

Recommended Immunization Schedule for Ages 0 to 18 Years

January 21, 2010

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.

Mood Disorder Treatments

January 12, 2010

Mood disorder treatments for bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.

Please take this short survey

and let us know.

COLORECTAL CANCER AWARENESS MONTH

This March, MPR is honoring
Colorectal Cancer Awareness Month with a special drug information newsletter containing state-of-the-art information on the diagnosis, treatment, and prevention for colorectal cancer, as well as intriguing new research

View this month's MPR Seasonal Spotlight

Subscribe to the MPR Seasonal Spotlight